Provided by Tiger Fintech (Singapore) Pte. Ltd.

JUNSHI BIO

15.060
+0.4603.15%
Volume:2.02M
Turnover:30.30M
Market Cap:14.84B
PE:-6.05
High:15.240
Open:14.780
Low:14.780
Close:14.600
Loading ...

Shanghai Junshi Biosciences - Unit Granted Certificate of Drug/Product Registration Issued by Pharmacy and Poisons Board of Hong Kong

THOMSON REUTERS
·
15 Oct 2024

Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAR

THOMSON REUTERS
·
15 Oct 2024

Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%

Simply Wall St.
·
15 Oct 2024

Stock Track | JUNSHI BIO Stock Drops Despite Cholesterol Drug Approval

Stock Track
·
14 Oct 2024

Shanghai Junshi Biosciences' Cholesterol Drug Gets NDA from NMPA; Shares Down 5%

MT Newswires Live
·
14 Oct 2024

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Simply Wall St.
·
30 Sep 2024

Junshi Biosciences Gets Rights for IAMA-001 Nasal Spray in Greater China; Shares Soar 10%

MT Newswires Live
·
27 Sep 2024

Junshi Biosciences Gets Nod to Trial WJ47156 Tablets as Tumor Drug; Shares Soar 10%

MT Newswires Live
·
27 Sep 2024

BRIEF-Shanghai Junshi Biosciences Says Js125 Received Notice Of Approval- For Clinical Trial

Reuters
·
27 Sep 2024

Stock Track | Junshi Biosciences Soars on New Licensing Deal for Nasal Spray Project

Stock Track
·
26 Sep 2024

BRIEF-Shanghai Junshi Biosciences Unit Entered Into License, Cooperation Agreement

Reuters
·
26 Sep 2024

Shanghai Junshi Biosciences - Unit and Nanjing Jsiama Biopharmaceuticals Entered Into License, Cooperation Agreement for Iama-001 Nasal Spray Project

THOMSON REUTERS
·
26 Sep 2024

Shanghai Junshi Biosciences -Js125 Received Notice of Approval- for Clinical Trial

THOMSON REUTERS
·
26 Sep 2024

Shanghai Junshi Biosciences - Investigational New Drug Application for Wj47156 Tablets Has Been Approved by Nmpa

THOMSON REUTERS
·
26 Sep 2024

Junshi Biosciences' Cancer Drug Gets Approval for 2 Indications from European Commission

MT Newswires Live
·
25 Sep 2024

BUZZ-Shanghai Junshi Biosciences rises on EC's approval for marketing Toripalimab

Reuters
·
25 Sep 2024